HOUSE-BILL 4184: H.R.4184 - To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.
AI-Powered Summary
HOUSE-BILL 4184 aims to enhance participation in clinical trials by providing a tax exclusion for compensation received by individuals involved in approved clinical trials. This legislation addresses major themes of healthcare accessibility and financial equity, ensuring that payments for participation do not count as gross income, which may increase the financial feasibility for individuals considering participation in such trials. Key provisions include the definition of 'qualified clinical trial payments' to encompass both compensation and reimbursement for related expenses, and the assurance that these payments will not impact eligibility for federal or state assistance programs. The bill is set to take effect for amounts paid after December 31, 2025. Potential implications include the promotion of clinical trial participation without financial penalty, while also raising constitutional considerations regarding equal treatment and the role of the federal government in income exclusions. Overall, the bill seeks to balance the interests of participants with regulatory frameworks, aiming to foster a more inclusive environment for clinical research.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill enhances individual rights by providing financial protections for those participating in clinical trials, which can lead to increased participation in potentially life-saving research. This is particularly significant for individuals from lower socioeconomic backgrounds who may rely on assistance programs.
Key Individual Rights Affected
- Equal Protection under the law
- Due Process regarding eligibility for assistance programs
- Right to Privacy concerning health information
Constitutional Provisions Most Relevant
- 14th Amendment - Equal Protection Clause
- 14th Amendment - Due Process Clause
Potential Constitutional Challenges Or Support
While the bill supports vulnerable populations by ensuring that trial compensation does not disqualify them from assistance, it may inadvertently create disparities among demographic groups due to systemic barriers in accessing clinical trials. Additionally, there are concerns about the potential for exploitation of individuals in vulnerable positions, which could raise ethical and constitutional questions.
Summary Of How This Bill Pertains To Individuals
HOUSE-BILL 4184 provides significant financial relief to individuals participating in clinical trials, encouraging broader participation and potentially improving public health outcomes. However, it is essential to monitor its implementation to ensure equitable access and protect individuals' rights, particularly regarding privacy and the potential for exploitation.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 4184 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
June 26, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat